INACTIVE/DISSOLVED
Founded
31 Dec 1994
Address
Burrill & Co LLC
One Embarcadero Center
Suite 2700
San Francisco, CA 94111
United States
Phone
Website
Industry
VCID: 2488
Profile
Founders
Corporate information
Registration country
Registration country
Investment activity status
Not investing
Company type
Diversified global financial services firm focused on the life sciences industryFunds managed
| Fund | Type | Vintage |
|---|---|---|
| Burrill Life Sciences Capital Fund IV | 2011 |
|
| Burrill Capital Fund IV LP | Venture |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Strand Life Sciences Pvt Ltd |
India | 11 Feb 2013 | Series B Active |
|
|
|
Ceptaris Therapeutics Inc Specialty pharmaceuticals company. |
United States | 1 Jun 2012 | Series D Active |
|
|
WaveTec Vision Systems Inc |
United States | 1 Apr 2012 | Venture Initial investment. Round participant. Active |
|
|
|
Endocyte Inc Folate-based cancer and autoimmune disease therapies |
United States | 1 Jan 2010 | Series C |
|
|
|
Aerovance Inc |
United States | 1 Apr 2009 1 Mar 2007 |
N/A Active |
|
|
|
Catalyst Biosciences Inc Developer of catalytic biopharmaceutical products based on engineered human proteases. |
United States | 1 Dec 2008 1 Feb 2006 1 Oct 2004 |
Series C |
|
|
|
Arete Therapeutics Inc A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. |
United States | 1 Nov 2008 | Series A |
|
|
|
Osprey Pharmaceuticals USA |
United States | 1 May 2008 | Series A |
|
|
|
Light Sciences Oncology Inc Drug-device cancer therapy |
United States | 1 Jul 2007 | Series B |
|
|
diaDexus Inc Biotechnology company focused on the discovery, development & commercialization of novel, patent protected diagnostic product with high clinical value |
United States | 1 Jan 2007 | Series E Active |
|
|
|
Neurotech Pharmaceuticals Inc Cell-based drugs for diseases of the eye. |
United States | 1 Nov 2006 | Series B |
|
|
|
Sciona Inc Provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. |
United States | 1 Apr 2006 1 Sep 2004 |
Series C Active |
|
|
|
XDx Inc |
United States | 5 Jan 2006 | N/A Initial investment. Round participant. Active |
|
|
|
Adlyfe |
United States | 1 Jan 2006 | Series A Active |
|
|
|
Intranasal Therapeutics Inc Specialty pharmaceutical company focused on developing nasally delivered pharmaceutical products. |
United States | N/A |
||
|
|
Immunicon Corp Biotechnology company specializing in cell-based research and diagnostic products with an initial focus on cancer. |
United States | N/A |